Clinical Perspective "GLP-1 medications can offer real short-term benefits in terms of appetite reduction and early weight loss, but it is important to have realistic expectations about what happens when stopping GLP-1 medication," says Alessandro Grenci, Superintendent Pharmacist at Medino
For health systems, these findings endorse the broader application of GLP-1 therapies to mitigate cardiovascular risk in everyday practice
THE COMPLETE ZERO SUGAR HYDRATION: Hydrate fast with an advanced blend of 6 key electrolytes and 15 essential vitamins and nutrientsbuilt to support clean living, performance, and recovery
Moderator: Dr Catherine Duggan, CEO, FIP, The Netherlands Panellists: - Dr Teddie Potter, Clinical Professor, Director of the Center for Planetary Health and Environmental Justice, School of Nursing, University of Minnesota, USA - Dr Filip Maric, Associate Professor, UiT The Arctic University of Norway, Environmental Physiotherapy Association, Norway - Clarisse Delorme, Senior Policy Advisor, WMA, France - Edward Krisiunas, President, WNWN International, Inc., USA - Dr Steven Mulligan, Dentist/ Clinical Teacher/ Founding member of FDI WDF Sustainability Task Team, FDI, UK Watch video Digital event video 5 June 2025, 14:00 - 15:30 CEST Expanding the Scope of Pharmacy Practice - The Role of a Sports Pharmacist More Most African countries do not have the role of sports pharmacy in their countries
The double-tagged bait protein is expressed at near natural levels, since overexpression may trigger non-physiological interactions
Key Point: Which Medications Are GLP-1 Agonists